Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 1 de 1
Filtrer
Plus de filtres











Base de données
Gamme d'année
1.
J Immunol Res ; 2021: 5511841, 2021.
Article de Anglais | MEDLINE | ID: mdl-33997054

RÉSUMÉ

Dengue is a worldwide expanding threat caused by dengue virus (DENV) infection. To date, no specific treatment or effective vaccine is available. Antibodies produced by plasma cells (PCs) might be involved concomitantly in protection and severe dengue immunopathology. Although a massive appearance of PCs has been reported during acute DENV infection in humans, this response has been poorly characterized. Here, we show the dynamic of PC generation in immune-competent mice cutaneously inoculated with DENV compared with two control experimental groups: mice inoculated with inactivated DENV or with PBS. We found that PC numbers increased significantly in the skin-draining lymph node (DLN), peaking at day 10 and abruptly decreasing by day 14 after DENV inoculation. Class-switched IgG+ PCs appeared from day 7 and dominated the response, while in contrast, the frequency of IgM+ PCs decreased from day 7 onwards. Even though the kinetic of the response was similar between DENV- and iDENV-inoculated mice, the intensity of the response was significantly different. Interestingly, we demonstrated a similar PC response to virus antigens (E and prM) by ELISPOT. In situ characterization showed that PCs were distributed in the medullary cords and in close proximity to germinal centers (GCs), suggesting both an extrafollicular and a GC origin. Proliferating PCs (Ki-67+) were found as early as 3-day postinoculation, and in-depth analysis showed that these PCs were in active phases of cell cycle during the kinetic. Finally, we found a progressive appearance of high-affinity neutralizing DENV-specific IgG further supporting GC involvement. Of note, these antibodies seem to be highly cross-reactive, as a large proportion recognizes Zika virus (ZIKV). The strong PC response to skin-inoculated DENV in this work resembles the findings already described in humans. We consider that this study contributes to the understanding of the in vivo biology of the humoral immune response to DENV in an immunocompetent murine model.


Sujet(s)
Virus de la dengue/immunologie , Dengue/immunologie , Plasmocytes/immunologie , Animaux , Anticorps neutralisants/analyse , Anticorps neutralisants/métabolisme , Anticorps antiviraux/analyse , Anticorps antiviraux/métabolisme , Réactions croisées , Dengue/anatomopathologie , Dengue/virologie , Modèles animaux de maladie humaine , Centre germinatif/cytologie , Centre germinatif/immunologie , Centre germinatif/métabolisme , Humains , Mâle , Souris , Plasmocytes/métabolisme , Peau/immunologie , Peau/anatomopathologie , Peau/virologie , Organismes exempts d'organismes pathogènes spécifiques , Virus Zika/immunologie
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE